J Preibisz

1.2k total citations
19 papers, 716 citations indexed

About

J Preibisz is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, J Preibisz has authored 19 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in J Preibisz's work include Cardiac Valve Diseases and Treatments (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). J Preibisz is often cited by papers focused on Cardiac Valve Diseases and Treatments (4 papers), Cardiovascular Function and Risk Factors (4 papers) and Analytical Methods in Pharmaceuticals (3 papers). J Preibisz collaborates with scholars based in United States and Poland. J Preibisz's co-authors include Jean E. Sealey, John H. Laragh, Phyllis G. Supino, Jeffrey Borer, Robert Cody, B B Weksler, Steven A. Atlas, Franco Müller, Mark S. Pecker and Thomas G. Pickering and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Journal of the American College of Cardiology.

In The Last Decade

J Preibisz

19 papers receiving 679 citations

Peers

J Preibisz
Frank Muders Germany
Onkar S. Dhillon United Kingdom
Russell J. O’Brien United Kingdom
Donald J. Breslin United States
M. J. Fiksen-Olsen United States
Ian Loke United Kingdom
V.T.F. Yeung Hong Kong
F Kaindl Austria
Frank Muders Germany
J Preibisz
Citations per year, relative to J Preibisz J Preibisz (= 1×) peers Frank Muders

Countries citing papers authored by J Preibisz

Since Specialization
Citations

This map shows the geographic impact of J Preibisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Preibisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Preibisz more than expected).

Fields of papers citing papers by J Preibisz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Preibisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Preibisz. The network helps show where J Preibisz may publish in the future.

Co-authorship network of co-authors of J Preibisz

This figure shows the co-authorship network connecting the top 25 collaborators of J Preibisz. A scholar is included among the top collaborators of J Preibisz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Preibisz. J Preibisz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Supino, Phyllis G., Jeffrey Borer, J Preibisz, Edmund M. Herrold, & Monica M. Diaz. (2010). PREOPERATIVE EXERCISE CAPACITY BEST PREDICTS SURVIVAL AFTER SURGERY FOR CHRONIC NONISCHEMIC MITRAL REGURGITATION. Journal of the American College of Cardiology. 55(10). A148.E1389–A148.E1389. 1 indexed citations
2.
Supino, Phyllis G., Jeffrey Borer, Joseph A. Franciosa, et al.. (2008). Acceptability and Psychometric Properties of the Minnesota Living With Heart Failure Questionnaire Among Patients Undergoing Heart Valve Surgery: Validation and Comparison With SF-36. Journal of Cardiac Failure. 15(3). 267–277. 50 indexed citations
3.
Supino, Phyllis G., Jeffrey Borer, Anuj Gupta, et al.. (2007). Prognostic Value of Exercise Tolerance Testing in Asymptomatic Chronic Nonischemic Mitral Regurgitation. The American Journal of Cardiology. 100(8). 1274–1281. 25 indexed citations
4.
Supino, Phyllis G., et al.. (2006). The Epidemiology of Valvular Heart Disease: a Growing Public Health Problem. Heart Failure Clinics. 2(4). 379–393. 116 indexed citations
5.
Supino, Phyllis G., Jeffrey Borer, Edmund M. Herrold, et al.. (2005). Prognostic Impact of Systolic Hypertension on Asymptomatic Patients With Chronic Severe Aortic Regurgitation and Initially Normal Left Ventricular Performance at Rest. The American Journal of Cardiology. 96(7). 964–970. 10 indexed citations
6.
Preibisz, J. (1993). Calcitonin Gene-Related Peptide and Regulation of Human Cardiovascular Homeostasis. American Journal of Hypertension. 6(5_Pt_1). 434–450. 58 indexed citations
7.
Sealey, Jean E., Nicola Glorioso, Joseph Itskovitz, et al.. (1987). Ovarian Prorenin. Clinical and Experimental Hypertension Part A Theory and Practice. 9(8-9). 1435–1454. 6 indexed citations
8.
Bosl, George J., S P Leitner, Steven A. Atlas, et al.. (1987). Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours. International Journal of Andrology. 10(1). 353–357. 1 indexed citations
9.
Resnick, L. M., J Preibisz, Jean E. Sealey, & John H. Laragh. (1986). Human calcitonin gene related peptide evidence for a physiologic role in blood pressure and calcium homeostasis. Hypertension. 8(9). 831. 2 indexed citations
10.
Cody, Robert, Spencer H. Kubo, Andrew B. Covit, et al.. (1986). Regional blood flow and neurohormonal responses to milrinone in congestive heart failure. Clinical Pharmacology & Therapeutics. 39(2). 128–135. 15 indexed citations
11.
Müller, Franco, Jean E. Sealey, David B. Case, et al.. (1986). The captopril test for identifying renovascular disease in hypertensive patients. The American Journal of Medicine. 80(4). 633–644. 154 indexed citations
12.
Bosl, George J., S P Leitner, Steven A. Atlas, et al.. (1986). Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors.. Journal of Clinical Oncology. 4(11). 1684–1689. 38 indexed citations
13.
Preibisz, J, Jean E. Sealey, John H. Laragh, Robert Cody, & B B Weksler. (1983). Plasma and platelet vasopressin in essential hypertension and congestive heart failure.. Hypertension. 5(2_pt_2). I129–38. 144 indexed citations
14.
Butler, V P, et al.. (1982). The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metabolite.. Journal of Pharmacology and Experimental Therapeutics. 221(1). 123–131. 17 indexed citations
15.
Preibisz, J, et al.. (1974). Digoxin Tablet Bioavailability: Single-Dose and Steady-State Assessment. Annals of Internal Medicine. 81(4). 469–474. 20 indexed citations
16.
Lindenbaum, John, J Preibisz, Vincent P. Butler, & Jnan R. Saha. (1973). Variation in digoxin bioavailability: A continuing problem. Journal of Chronic Diseases. 26(12). 749–754. 10 indexed citations
17.
Rymaszewski, Z, et al.. (1972). Clinical evaluation of practolol in acute arrhythmias.. Heart. 34(3). 260–262. 2 indexed citations
18.
Januszewicź, W, et al.. (1971). Urinary excretion of dopamine and homovanillic acid in acute myocardial infarction. Clinica Chimica Acta. 32(2). 261–264. 5 indexed citations
19.
Januszewicź, W, et al.. (1968). Urinary excretion of free norepinephrine and free epinephrine in patients with acute myocardial infarction in relation to its clinical course. American Heart Journal. 76(3). 345–352. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026